Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

FFoghorn Therapeutics Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
F

Foghorn Therapeutics Inc.

$4.24Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $16.07M. Net result −$7.19M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $16.07M. Running result $16.07M. Revenue: $16.07M.
  • Cost of revenue: $0. Running result $16.07M.
  • Gross profit: $16.07M. Running result $16.07M.
  • Research and development: −$18.52M. Running result −$2.45M.
  • General and administrative: −$6.35M. Running result −$8.81M.
  • Operating income: −$8.81M. Running result −$8.81M.
  • Other income: $1.61M. Running result −$7.19M.
  • Pre-tax loss: −$7.19M. Running result −$7.19M.
  • Income tax benefit: $0. Running result −$7.19M.
  • Net loss: −$7.19M. Running result −$7.19M.